Mutations in sphingolipid metabolism genes are associated with ADHD

[1]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[2]  Johnny S. H. Kwan,et al.  Sharing of Genes and Pathways Across Complex Phenotypes: A Multilevel Genome-Wide Analysis , 2017, Genetics.

[3]  Alan M. Zaslavsky,et al.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[4]  W. Driever,et al.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility , 2016, Biological Psychiatry.

[5]  Elizabeth B. Owens,et al.  Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  S. Faraone,et al.  Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies , 2016, Molecular Psychiatry.

[7]  Larry N. Singh,et al.  Altering the Mitochondrial Fatty Acid Synthesis (mtFASII) Pathway Modulates Cellular Metabolic States and Bioactive Lipid Profiles as Revealed by Metabolomic Profiling , 2016, PloS one.

[8]  L. Rohde,et al.  Genetics of attention-deficit/hyperactivity disorder: an update , 2016, Expert review of neurotherapeutics.

[9]  F. Castellanos,et al.  Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate , 2015, Molecular Psychiatry.

[10]  R. Deckelbaum,et al.  Low serum sphingolipids in children with attention deficit-hyperactivity disorder , 2015, Front. Neurosci..

[11]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[12]  R. Elston,et al.  Defining “mutation” and “polymorphism” in the era of personal genomics , 2015, BMC Medical Genomics.

[13]  C. Zeni,et al.  LPHN3 and attention‐deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study , 2015, Genes, brain, and behavior.

[14]  R. Maude,et al.  Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker , 2015, The Lancet. Infectious diseases.

[15]  P. Shaw,et al.  White Matter Microstructure and the Variable Adult Outcome of Childhood Attention Deficit Hyperactivity Disorder , 2015, Neuropsychopharmacology.

[16]  T. Cummins,et al.  The molecular genetic architecture of attention deficit hyperactivity disorder , 2015, Molecular Psychiatry.

[17]  S. MacGregor,et al.  VEGAS2: Software for More Flexible Gene-Based Testing , 2014, Twin Research and Human Genetics.

[18]  Y. Li,et al.  Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations , 2014, Genome Medicine.

[19]  Suhua Chang,et al.  Molecular genetic studies of ADHD and its candidate genes: A review , 2014, Psychiatry Research.

[20]  A. Kozubík,et al.  DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in sphingolipid metabolism. , 2014, Biochimica et biophysica acta.

[21]  G. Salum,et al.  ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. , 2013, International journal of epidemiology.

[22]  F. Castellanos,et al.  White Matter Alterations at 33-Year Follow-Up in Adults with Childhood Attention-Deficit/Hyperactivity Disorder , 2013, Biological Psychiatry.

[23]  J. Degen,et al.  Inactivation of Ceramide Synthase 6 in Mice Results in an Altered Sphingolipid Metabolism and Behavioral Abnormalities* , 2013, The Journal of Biological Chemistry.

[24]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[25]  Yadong Huang,et al.  Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development , 2013, PloS one.

[26]  A. Thapar,et al.  Practitioner Review: What have we learnt about the causes of ADHD? , 2013, Journal of Child Psychology and Psychiatry, and Allied Disciplines.

[27]  J. Degen,et al.  Ablation of Neuronal Ceramide Synthase 1 in Mice Decreases Ganglioside Levels and Expression of Myelin-associated Glycoprotein in Oligodendrocytes* , 2012, The Journal of Biological Chemistry.

[28]  Bjarni J. Vilhjálmsson,et al.  An efficient multi-locus mixed model approach for genome-wide association studies in structured populations , 2012, Nature Genetics.

[29]  Dirk J. Heslenfeld,et al.  Diffusion tensor imaging in attention deficit/hyperactivity disorder: A systematic review and meta-analysis , 2012, Neuroscience & Biobehavioral Reviews.

[30]  M. Gill,et al.  Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD , 2012, The American journal of psychiatry.

[31]  S. Scherer,et al.  Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 , 2012, The American journal of psychiatry.

[32]  Yong He,et al.  Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood. , 2011, Archives of general psychiatry.

[33]  Alfred H. Merrill,et al.  Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.

[34]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[35]  H. Hakonarson,et al.  A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD , 2011, Molecular Psychiatry.

[36]  Inke R. König,et al.  Validation in Genetic Association Studies , 2011, Briefings Bioinform..

[37]  Fassnacht,et al.  Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.

[38]  B. Franke,et al.  Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.

[39]  Johnny S. H. Kwan,et al.  GATES: a rapid and powerful gene-based association test using extended Simes procedure. , 2011, American journal of human genetics.

[40]  Deepti R. Bathula,et al.  Altered white matter microstructure in children with attention-deficit/hyperactivity disorder. , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[41]  P. Sham,et al.  A Knowledge-Based Weighting Framework to Boost the Power of Genome-Wide Association Studies , 2010, PloS one.

[42]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[43]  D. Cooper,et al.  Identification and Characterization of 15 Novel GALC Gene Mutations Causing Krabbe Disease , 2010, Human mutation.

[44]  C. Freitag,et al.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.

[45]  V. Bansal,et al.  Statistical analysis strategies for association studies involving rare variants , 2010, Nature Reviews Genetics.

[46]  S. Nelson,et al.  Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[47]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[48]  S. Sipione,et al.  Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction , 2010, FEBS letters.

[49]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[50]  Peter Kraft,et al.  Replication in genome-wide association studies. , 2009, Statistical science : a review journal of the Institute of Mathematical Statistics.

[51]  J. Degen,et al.  Adult Ceramide Synthase 2 (CERS2)-deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and Hepatocarcinomas* , 2009, The Journal of Biological Chemistry.

[52]  N. Rinehart,et al.  White‐matter abnormalities in attention deficit hyperactivity disorder: A diffusion tensor imaging study , 2009, Human brain mapping.

[53]  J. Swanson,et al.  The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[54]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[55]  S. Bálint,et al.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis , 2009, British Journal of Psychiatry.

[56]  E. Schuchman,et al.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  B. Franke,et al.  Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. , 2008, American journal of human genetics.

[58]  M. Muenke,et al.  Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[59]  H. Kraemer,et al.  Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) , 2008, Journal of attention disorders.

[60]  Y. Hirabayashi,et al.  Roles of l-serine and sphingolipid synthesis in brain development and neuronal survival. , 2008, Progress in lipid research.

[61]  Henrik,et al.  A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16 , 2008, Molecular Psychiatry.

[62]  Rebecca F. Halperin,et al.  Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 , 2008, Molecular Psychiatry.

[63]  Chunyan Liu,et al.  Comparison of false-discovery rate for genome-wide and fine mapping regions , 2007, BMC proceedings.

[64]  Alan C. Evans,et al.  Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation , 2007, Proceedings of the National Academy of Sciences.

[65]  Robert D Gibbons,et al.  3-year follow-up of the NIMH MTA study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[66]  L. Horrocks,et al.  Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide , 2007, Journal of neuroscience research.

[67]  L. Rohde,et al.  Epidemiology of attention-deficit/hyperactivity disorder across the lifespan , 2007, Current opinion in psychiatry.

[68]  F. Castellanos,et al.  Attention-Deficit/Hyperactivity Disorder and Comorbid Disruptive Behavior Disorders: Evidence of Pleiotropy and New Susceptibility Loci , 2007, Biological Psychiatry.

[69]  Philip Shaw,et al.  Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. , 2007, The American journal of psychiatry.

[70]  E. Taylor,et al.  Association of Fatty Acid Desaturase Genes with Attention-Deficit/Hyperactivity Disorder , 2006, Biological Psychiatry.

[71]  M. Ameloot,et al.  Rafts in oligodendrocytes: Evidence and structure–function relationship , 2006, Glia.

[72]  J Sergeant,et al.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes , 2006, Molecular Psychiatry.

[73]  K Konrad,et al.  A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs , 2006, Molecular Psychiatry.

[74]  Peter Thier,et al.  Disturbed overt but normal covert shifts of attention in adult cerebellar patients. , 2005, Brain : a journal of neurology.

[75]  J. Rapoport,et al.  Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[76]  L. Colombaioni,et al.  Sphingolipid metabolites in neural signalling and function , 2004, Brain Research Reviews.

[77]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[78]  J. Schmahmann,et al.  Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[79]  Leonard Bickman,et al.  Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. , 2003, Journal of pediatric psychology.

[80]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[81]  Christoph Lange,et al.  A multivariate family-based association test using generalized estimating equations: FBAT-GEE. , 2003, Biostatistics.

[82]  Christoph Lange,et al.  Power calculations for a general class of family-based association tests: dichotomous traits. , 2002, American journal of human genetics.

[83]  Christoph Lange,et al.  On a general class of conditional tests for family‐based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations , 2002, Genetic epidemiology.

[84]  H. Kraemer,et al.  Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[85]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[86]  A. Brookes.  The essence of SNPs. , 1999, Gene.

[87]  E. Taylor,et al.  Attention-deficit hyperactivity disorder and hyperkinetic disorder , 1998, The Lancet.

[88]  J. Desmond,et al.  Lobular Patterns of Cerebellar Activation in Verbal Working-Memory and Finger-Tapping Tasks as Revealed by Functional MRI , 1997, The Journal of Neuroscience.

[89]  P. Wender,et al.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. , 1993, The American journal of psychiatry.

[90]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[91]  R. Fisher.  Statistical methods for research workers , 1927, Protoplasma.

[92]  J. C. Correa,et al.  A New Method for Detecting Significant p-values with Applications to Genetic Data , 2014 .

[93]  Y. Pewzner‐Jung,et al.  Ceramide synthases: reexamining longevity. , 2013, Handbook of experimental pharmacology.

[94]  T. Worgall.  Sphingolipid synthetic pathways are major regulators of lipid homeostasis. , 2011, Advances in experimental medicine and biology.

[95]  Y. Hannun,et al.  An overview of sphingolipid metabolism: from synthesis to breakdown. , 2010, Advances in experimental medicine and biology.

[96]  Tao Jiang,et al.  Genetics and population analysis Haplotype-based linkage disequilibrium mapping via direct data mining , 2005 .

[97]  S. Keele,et al.  Dissociation of the lateral and medial cerebellum in movement timing and movement execution , 2004, Experimental Brain Research.

[98]  W. Reich.  Diagnostic interview for children and adolescents (DICA) , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[99]  Xin Xu,et al.  Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.

[100]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[101]  Attention-Deficit/Hyperactivity Disorder in a Population Isolate: Linkage to Loci at 4q13.2, 5q33.3, 11q22, and 17p11 , 2022 .